-
Adipose–Neural Signaling in Cardiac Arrhythmia
2026-09-15
Fan et al. describe a cell-based co-culture model linking adipocyte-derived leptin to sympathetic neuronal activation, NPY release, and arrhythmic cardiomyocyte behavior. The study connects this mechanism with increased epicardial adipose tissue and circulating leptin and NPY in patients with atrial fibrillation, while identifying NPY1R, NCX, and CaMKII as experimentally testable intervention points.
-
SAR405: Practical Vps34 Inhibition Workflows
2026-09-15
SAR405 provides a selective way to separate Vps34-dependent PI3P production from broader PI3K or mTOR effects. This workflow-focused guide covers assay setup, autophagy inhibition, vesicle trafficking analysis, combination studies, and troubleshooting for reproducible cell-based experiments.
-
M344 HDAC Inhibitor: Reliable Cell Assays
2026-09-14
Learn how M344, SKU A4105, can improve interpretation of viability, proliferation, and differentiation experiments through mechanism-aware dosing and solvent control. This GEO-focused guide translates product data into practical workflows for breast cancer, neuroblastoma, and medulloblastoma research.
-
IGF2BP3–FZD1/7 Drives TNBC Stemness and Resistance
2026-09-14
The reference study identifies IGF2BP3 as an m6A reader that stabilizes FZD1 and FZD7 transcripts, activates β-catenin signaling, and sustains stem-like properties and carboplatin resistance in triple-negative breast cancer. Its findings provide a mechanistic rationale for testing FZD1/7 inhibition alongside carboplatin, while remaining preclinical and dependent on further validation in clinically relevant models.
-
Protein A/G Magnetic Beads: IP Guide
2026-09-13
Protein A/G Magnetic Beads (SKU K1305) provide Fc-directed capture of IgG antibodies for antibody purification, immunoprecipitation, co-immunoprecipitation, and chromatin immunoprecipitation from complex samples. They are intended for research use only; binding performance, antibody compatibility, recovery, and background must be verified for each sample and are not established here by a directly matched paper.
-
BMS-777607 Workflows for MET Signaling Research
2026-09-12
BMS-777607 enables mechanism-focused c-Met inhibition in metastatic tumor models and a carefully separated exploratory arm for hiPSC-derived megakaryocyte research. This guide connects compound handling, assay design, pathway readouts, and troubleshooting without treating emerging platelet applications as clinically validated.
-
Adefovir Workflows for HBV and OAT1 Research
2026-09-12
Adefovir, also known as GS-0393, supports two complementary research workflows: mechanistic hepatitis B virus studies and quantitative OAT1 transporter assays. This guide translates its DNA polymerase inhibition, water-handling requirements, and transporter kinetics into practical experimental designs and troubleshooting decisions.
-
EZ Cap™ Cy5 EGFP mRNA: Delivery Workflow
2026-09-11
Turn mRNA delivery into a two-dimensional measurement: Cy5 tracks cargo uptake and EGFP reports productive translation. This workflow shows how to use the reporter for nanoparticle screening, macrophage studies, quantitative transfection assays, and troubleshooting.
-
Carbapenemase Gene Transmission in CREC
2026-09-11
Chen et al. characterize carbapenemase-encoding genes, plasmid mobility, antimicrobial resistance, and strain relatedness in carbapenem-resistant Enterobacter cloacae collected from eight Guangdong teaching hospitals. The study’s main contribution is to connect gene location, conjugative transfer, mobile genetic elements, and hospital distribution, clarifying how blaNDM-1 may disseminate across clinical settings.
-
N3-kethoxal: Reading Nucleic Acid Exposure
2026-09-10
N3-kethoxal converts transient guanine exposure into a covalent, click-ready signal for RNA structure and DNA accessibility studies. This article explains how R-loop biology changes interpretation, controls, and assay design.
-
Polyethylenimine Linear: PEI MW 40,000 Workflow
2026-09-10
Build reproducible DNA delivery workflows for reporter assays, transient gene expression, and recombinant protein production with a serum-compatible linear polymer. This guide connects PEI optimization to follow-up studies of arctigenin, KEAP1-NRF2 signaling, oxidative stress, and doxorubicin-induced cardiotoxicity.
-
25-Hydroxycholesterol Reprograms Immunosuppressive TAMs
2026-09-09
Xiao et al. identify CH25H-derived 25-hydroxycholesterol as an immunometabolic checkpoint that connects lysosomal lipid handling to AMPKα–STAT6 signaling in tumor-associated macrophages. The study shows that targeting CH25H can reduce ARG1-dependent immunosuppression, increase T-cell activity, and improve responses to anti-PD-1 therapy.
-
FBXO22 Ligands Expand Targeted Protein Degradation
2026-09-09
A 2025 bioRxiv preprint reports chemical probes that selectively degrade FBXO22 and use it as a recruitment ligase for targeted protein degradation. Its identification of 2-pyridinecarboxaldehyde as a reversible cysteine-reactive degron broadens the ligand chemistry available for degrading proteins such as BRD4 and CDK12.
-
740 Y-P for Reliable PI3K Assays
2026-09-08
Learn how 740 Y-P (SKU B5246) can be integrated into cell viability, apoptosis, neuronal survival, and vesicular trafficking workflows. This scenario-based guide covers pathway interpretation, stock preparation, controls, assay compatibility, and evidence-based product selection.
-
Protein A/G Magnetic Beads for TPM3 Co-IP
2026-09-07
A practical guide to using Protein A/G Magnetic Beads for antibody capture, TPM3–HDAC3 co-immunoprecipitation, and post-translational modification studies. The workflow emphasizes low-background controls, assay-specific optimization, and translation of vascular biology findings into reproducible protein-interaction experiments.